Patent · US Active

Anti-tumor drug, medicament, composition, and use thereof

US8188044B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

GENE SIGNAL INTERNATIONAL SA · CH

Inventors

Sylvie Colin · Paris, FR
Salman Al-Mahmood · Paris, FR

Key dates

Filing date	Oct 29, 2009
Grant date	May 29, 2012
Priority date	—
Expiry date	Dec 4, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/47
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An active polypeptide comprising the amino acid sequence of SEQ ID NO: 3, or having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of SEQ ID NO: 3, or fragments thereof having at least 21 contiguous amino acids, or peptides having at least 50%, preferably 70%, more preferably 90% identity with the amino acid sequence of the fragments, provided that the polypeptide is not SEQ ID NO: 2. A method for inhibiting cancer and/or tumor growth comprising administering to a subject in need thereof an effective amount of the active polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.